RACHEL SUK: Open Payments
NPI 1932829637 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 82 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $785 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $324 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $255 |
| Axsome Therapeutics, Inc. | 14 | $202 |
| Corium, LLC | 10 | $184 |
| ABBVIE INC. | 6 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Bausch Health US, LLC | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Tris Pharma Inc | 3 | $59 |
Products named: CAPLYTA, REXULTI, Auvelity, Azstarys, VRAYLAR, TRINTELLIX, APLENZIN, COBENFY.
Industry payments across MD — which companies pay providers there.
